FDA approves pancreatic cancer drug

Dr. Jeremy Kratz from UW-Madison discusses a groundbreaking FDA-approved pill for advanced pancreatic cancer. The drug targets the KRAS protein, doubling survival rates compared to second-line chemotherapy while offering a better quality of life and greater flexibility for patients.